These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29364462)

  • 21. Coexistence of borderline tuberculoid Hansen's disease with tuberculosis verrucosa cutis in a child--a rare case.
    Ravindra K; Sugareddy ; Ramachander T
    Indian J Lepr; 2010; 82(2):91-3. PubMed ID: 21434512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The frequency of the appearance of perforating foot ulcers in patients with Hansen's disease as a function of treatment with disulone alone or with polychemotherapy].
    Mane I; Grauwin MY; Cartel JL
    Acta Leprol; 1995; 9(3):127-31. PubMed ID: 7631583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immuno-allergic accidents with rifamipcin].
    Flageul B; Wagner L; Cottenot F
    Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dapsone: An Update.
    Karjigi S; Murthy SC; Kallappa H; Kusuma MR; Aruna B; Reddy YN
    Indian J Lepr; 2016 Sep; 87(4):233-239. PubMed ID: 29762952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Adverse effects of multidrug therapy in leprosy patients: a five-year survey at a Health Center of the Federal University of Uberlândia].
    Goulart IM; Arbex GL; Carneiro MH; Rodrigues MS; Gadia R
    Rev Soc Bras Med Trop; 2002; 35(5):453-60. PubMed ID: 12621663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dapsone syndrome with acute renal failure during leprosy treatment: case report.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Fontes CJ
    Braz J Infect Dis; 2005 Feb; 9(1):84-6. PubMed ID: 15947852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Problems of multidrug therapy.
    Ramu G
    Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
    [No Abstract]   [Full Text] [Related]  

  • 30. [Agranulocytosis induced by dapsone prescribed for dermatitis herpetiformis].
    Machet L; Callens A; Mercier E; Gargot S; Lorette G; Vaillant L
    Ann Dermatol Venereol; 1996; 123(5):328-30. PubMed ID: 8761086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leprosy in a preschool child--a case report.
    Arora SK
    J Indian Med Assoc; 2007 Mar; 105(3):140. PubMed ID: 17824468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Borderline tuberculoid leprosy and alopecia areata involving scalp.
    Dogra S; Kaur I; Kumar B
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):215-6. PubMed ID: 12483973
    [No Abstract]   [Full Text] [Related]  

  • 33. Association between HLA-B*1301 and dapsone-induced hypersensitivity reactions among leprosy patients in China.
    Wang H; Yan L; Zhang G; Chen X; Yang J; Li M; Shen J; Yu M; Huo R; Wang B
    J Invest Dermatol; 2013 Nov; 133(11):2642-2644. PubMed ID: 23604100
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary Neuritic Hansen's Disease presenting as Ulnar Nerve Abscess in a Human Immunodeficiency Virus Positive Patient.
    Karjigi S; Herakal K; Murthy SC; Bathina A; Kusuma MR; Nikhil KR
    Indian J Lepr; 2015; 87(3):169-74. PubMed ID: 26999990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 36. A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.
    Bhat RM; Radhakrishnan K
    Lepr Rev; 2003 Jun; 74(2):167-70. PubMed ID: 12862258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of acetylator phenotype on the haematological and biochemical effects associated with dapsone in leprosy patients.
    Queiroz RH; Souza AM; Melchior E; Gouveia EG; Carvalho D
    Lepr Rev; 1997 Sep; 68(3):212-7. PubMed ID: 9364821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leprosy after interleukin 6 inhibitor therapy in a patient with rheumatoid arthritis.
    Nambiar PH; Katikaneni M; Al Nahlawi B; Hayat SQ
    Lancet Infect Dis; 2019 Jul; 19(7):787. PubMed ID: 31250825
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on: Arthritis as presenting manifestation of pure neuritic leprosy--a rheumatologist's dilemma.
    Al Attia HM
    Rheumatology (Oxford); 2008 Jan; 47(1):110-1; author reply 111-2. PubMed ID: 18077500
    [No Abstract]   [Full Text] [Related]  

  • 40. Renal hypersensitivity vasculitis associated with dapsone.
    Alves-Rodrigues EN; Ribeiro LC; Silva MD; Takiuchi A; Rabel-Filho OC; Martini-Filho D; Fontes CJ
    Am J Kidney Dis; 2005 Oct; 46(4):e51-3. PubMed ID: 16183407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.